DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

127.89 1.59 (1.26%)

REAL-TIME: Last trade at

Extended Hours: $129.50 $1.61 (1.26%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

SLXP $127.89 1.26%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $127.05
Previous Close $126.30
Daily Range $126.07 - $129.31
52-Week Range $86.00 - $172.98
Market Cap $8.1B
P/E Ratio -100.24
Dividend (Yield) $0.00 (0.0%)
Volume 1,422,228
Average Daily Volume 1,610,705
Current FY EPS -$2.25

Sector

Healthcare

Industry

Drugs

Salix Pharmaceuticals, Ltd. (SLXP) Description

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. Website: http://www.salix.com/

News & Commentary Rss Feed

Why Salix Pharmaceuticals, Ltd. Stock Was Clobbered in November

Salix Pharmaceuticals gets clobbered in November after the integrity of its management team is called into question following its third-quarter earnings results.

Adamis Pharmaceuticals: A Specialty Pharma Ready For The Next Level

Benzinga's M&A Chatter for Tuesday January 20, 2015

Report: Salix Pharmaceuticals Exploring Possible Sale

Salix Pharmaceuticals (SLXP) Is Today's Storm The Castle Stock

RedHill Announces Milestones & Regulatory Events for 2015 - Analyst Blog

RedHill Announces Milestones & Regulatory Events for 2015 - Analyst Blog

Salix CEO to Step Down, Inventory Issues Remain in Focus - Analyst Blog

Benzinga's M&A Chatter for Thursday December 18, 2014

Credit Suisse Raises Salix Pharmaceuticals Price Target

Salix Gains on Destocking Initiatives, Gives 2-Year Outlook - Analyst Blog

#PreMarket Movers From December 16, 2014

See More SLXP News...

SLXP's Top Competitors

SLXP $127.89 (1.26%)
Current stock: SLXP
JNJ $101.48 (-0.60%)
Current stock: JNJ
NVS $97.11 (-1.84%)
Current stock: NVS
RHHBY $34.47 (-3.45%)
Current stock: RHHBY